198 related articles for article (PubMed ID: 21373641)
1. Newly engineered magnetic erythrocytes for sustained and targeted delivery of anti-cancer therapeutic compounds.
Cinti C; Taranta M; Naldi I; Grimaldi S
PLoS One; 2011 Feb; 6(2):e17132. PubMed ID: 21373641
[TBL] [Abstract][Full Text] [Related]
2. Magnetically driven drug delivery systems improving targeted immunotherapy for colon-rectal cancer.
Grifantini R; Taranta M; Gherardini L; Naldi I; Parri M; Grandi A; Giannetti A; Tombelli S; Lucarini G; Ricotti L; Campagnoli S; De Camilli E; Pelosi G; Baldini F; Menciassi A; Viale G; Pileri P; Cinti C
J Control Release; 2018 Jun; 280():76-86. PubMed ID: 29733876
[TBL] [Abstract][Full Text] [Related]
3. Design of an innovative platform for the treatment of cerebral tumors by means of erythro-magneto-HA-virosomes.
Lucarini G; Sbaraglia F; Vizzoca A; Cinti C; Ricotti L; Menciassi A
Biomed Phys Eng Express; 2020 May; 6(4):045005. PubMed ID: 33444266
[TBL] [Abstract][Full Text] [Related]
4. Erythro-Magneto-HA-Virosome: A Bio-Inspired Drug Delivery System for Active Targeting of Drugs in the Lungs.
Vizzoca A; Lucarini G; Tognoni E; Tognarelli S; Ricotti L; Gherardini L; Pelosi G; Pellegrino M; Menciassi A; Grimaldi S; Cinti C
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077300
[TBL] [Abstract][Full Text] [Related]
5. Novel drug delivery systems for sustained and targeted delivery of anti- cancer drugs: current status and future prospects.
Utreja P; Jain S; Tiwary AK
Curr Drug Deliv; 2010 Apr; 7(2):152-61. PubMed ID: 20158482
[TBL] [Abstract][Full Text] [Related]
6. Influenza virosomes as an efficient system for adjuvanted vaccine delivery.
Glück R; Moser C; Metcalfe IC
Expert Opin Biol Ther; 2004 Jul; 4(7):1139-45. PubMed ID: 15268680
[TBL] [Abstract][Full Text] [Related]
7. Development of a membrane fusible drug carrier from erythrocytes by the spontaneous transfer of viral fusion protein from influenza virus-infected cells.
Kogure K; Okuda O; Itoh T; Hayashi K; Ueno M
Biol Pharm Bull; 1997 May; 20(5):581-3. PubMed ID: 9178945
[TBL] [Abstract][Full Text] [Related]
8. Magnetic nanoparticle-based approaches to locally target therapy and enhance tissue regeneration in vivo.
Sensenig R; Sapir Y; MacDonald C; Cohen S; Polyak B
Nanomedicine (Lond); 2012 Sep; 7(9):1425-42. PubMed ID: 22994959
[TBL] [Abstract][Full Text] [Related]
9. Multifunctional nanomedicine platform for concurrent delivery of chemotherapeutic drugs and mild hyperthermia to ovarian cancer cells.
Taratula O; Dani RK; Schumann C; Xu H; Wang A; Song H; Dhagat P; Taratula O
Int J Pharm; 2013 Dec; 458(1):169-80. PubMed ID: 24091153
[TBL] [Abstract][Full Text] [Related]
10. Idarubicin-loaded folic acid conjugated magnetic nanoparticles as a targetable drug delivery system for breast cancer.
Gunduz U; Keskin T; Tansık G; Mutlu P; Yalcin S; Unsoy G; Yakar A; Khodadust R; Gunduz G
Biomed Pharmacother; 2014 Jul; 68(6):729-36. PubMed ID: 25194441
[TBL] [Abstract][Full Text] [Related]
11. Effect of substitution of hemagglutinin-neuraminidase with influenza hemagglutinin on Sendai virus F protein mediated membrane fusion.
Bagai S; Sarkar DP
FEBS Lett; 1994 Oct; 353(3):332-6. PubMed ID: 7957887
[TBL] [Abstract][Full Text] [Related]
12. Current trends in chemical modifications of magnetic nanoparticles for targeted drug delivery in cancer chemotherapy.
Gholami A; Mousavi SM; Hashemi SA; Ghasemi Y; Chiang WH; Parvin N
Drug Metab Rev; 2020 Feb; 52(1):205-224. PubMed ID: 32083952
[TBL] [Abstract][Full Text] [Related]
13. Doxorubicin loaded magnetic gold nanoparticles for in vivo targeted drug delivery.
Elbialy NS; Fathy MM; Khalil WM
Int J Pharm; 2015 Jul; 490(1-2):190-9. PubMed ID: 25997662
[TBL] [Abstract][Full Text] [Related]
14. Targeting influenza virosomes to ovarian carcinoma cells.
Mastrobattista E; Schoen P; Wilschut J; Crommelin DJ; Storm G
FEBS Lett; 2001 Nov; 509(1):71-6. PubMed ID: 11734208
[TBL] [Abstract][Full Text] [Related]
15. Applications of influenza virosomes as a delivery system.
Cusi MG
Hum Vaccin; 2006; 2(1):1-7. PubMed ID: 17012895
[TBL] [Abstract][Full Text] [Related]
16. Triple-Configurational Magnetic Robot for Targeted Drug Delivery and Sustained Release.
Chen W; Chen X; Yang M; Li S; Fan X; Zhang H; Xie H
ACS Appl Mater Interfaces; 2021 Sep; 13(38):45315-45324. PubMed ID: 34520665
[TBL] [Abstract][Full Text] [Related]
17. Development and Characterization of Magnetite/Poly(butylcyanoacrylate) Nanoparticles for Magnetic Targeted Delivery of Cancer Drugs.
López-Viota M; El-Hammadi MM; Cabeza L; Prados J; Melguizo C; Ruiz Martinez MA; Arias JL; Delgado ÁV
AAPS PharmSciTech; 2017 Nov; 18(8):3042-3052. PubMed ID: 28508129
[TBL] [Abstract][Full Text] [Related]
18. Enhanced Targeted Delivery of Cyclodextrin-Based Supermolecules by Core-Shell Nanocapsules for Magnetothermal Chemotherapy.
Lin IC; Fang JH; Lin CT; Sung SY; Su YL; Hu SH
Macromol Biosci; 2016 Sep; 16(9):1273-86. PubMed ID: 27328404
[TBL] [Abstract][Full Text] [Related]
19. Preparation, properties, and applications of reconstituted influenza virus envelopes (virosomes).
Bron R; Ortiz A; Dijkstra J; Stegmann T; Wilschut J
Methods Enzymol; 1993; 220():313-31. PubMed ID: 8350760
[No Abstract] [Full Text] [Related]
20. Cell-free protein synthesis of influenza virus hemagglutinin HA2-integrated virosomes for siRNA delivery.
Wang Y; Jin B; Li B; Luo Y; Ma M; Chen Y; Liu H; Xie H; Yang T; Zhao X; Ding P
Int J Pharm; 2022 Jul; 623():121890. PubMed ID: 35690307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
